As of the latest Form 4 filed Jul 8, 2026.
What Theravance Biopharma Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 14 most recent filings for TBPH.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-08 | 2026-07-07 | Samaha Eli 10% owner | SSale | −5.56K | $17.17 | $95.5K | No | Form 4 ↗ |
| 2026-07-08 | 2026-07-06 | Samaha Eli, 10% owner | SSale | −1.40K | $17.04 | $23.9K | No | Form 4 ↗ |
| 2026-07-01 | 2026-07-01 | Samaha Eli 10% owner | SSale | −37.8K | $17.00 | $643K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Samaha Eli, 10% owner | SSale | −25.0K | $17.13 | $429K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-29 | Samaha Eli, 10% owner | SSale | −274K | $17.23 | $4.72M | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-19 | Miller Aine SVP, DEV & HEAD OF IRE OFFICE | AAward | +18.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | SSale | −6.66K | $16.39 | $109K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Farnum Rhonda, SVP, COMM & MEDICAL AFFAIRS | SSale | −3.33K | $16.38 | $54.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Farnum Rhonda, SVP, COMM & MEDICAL AFFAIRS | SSale | −3.33K | $16.39 | $54.6K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | GRAY SUSANNAH Director | AAward | +6.01K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | O'Connor Donal Director | AAward | +6.01K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Smaldone Alsup Laurie Director | AAward | +6.01K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | PAKIANATHAN DEEPIKA Director | AAward | +6.01K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | MITCHELL DEAN J Director | AAward | +6.01K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also TBPH’s full analysis or the market-wide insider trading feed. The tabs above jump to TBPH’s other SEC data.
Source: SEC Form 4 filings for TBPH, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.